Eli Lilly's CEO Dave Ricks spoke with CNBC.
The company opposes the 'most favored nation' drug pricing proposal.
The push is part of a broader effort by the White House.
Strategic angle: Eli Lilly's CEO expresses opposition to the White House's efforts to codify drug pricing reforms.
Eli Lilly's CEO Dave Ricks spoke with CNBC.
The company opposes the 'most favored nation' drug pricing proposal.
The push is part of a broader effort by the White House.